Dark

Check out our API

BIIO
BIONOVATE TECHNOLOGIES
stock OTC

EOD

Jul 31, 2026

0.000100USD0.000%(0.000000)438

Pre-market

0.00USD-100.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

May 3, 2021

06:23AM EDT Bionovate Technologies Corp., traded on OTC Markets (OTCPK:BIIO), announced that it has submitted a formal application to list its common shares (Shares) on the NASDAQ Stock Exchange (NASDAQ). NASDAQ is the second largest exchange by market capitalization worldwide and is home to many of the worlds best technology companies. GlobeNewswire Inc

Apr 30, 2021

10:29AM EDT Bionovate Technologies Corp., traded on OTC Markets (OTCPK:BIIO), announces the cancellation and return to treasury of 25,000,000 common shares of the companys stock. The stock transactions will soon be represented in reports filed with the United States Securities and Exchange Commission (SEC). GlobeNewswire Inc

Mar 4, 2021

01:29PM EST Bionovate Technologies Corp (OTCMKT: BIIO) (Bionovate), is currently in the process of compiling a shortlist for potential investments in start-ups in the digital healthcare markets, as announced. The COVID-19 pandemic has accelerated the digital transformation of the healthcare market and launched numerous innovative start-ups. GlobeNewswire Inc

Dec 8, 2020

10:16AM EST Bionovate Technologies Corp., traded on the Nasdaq OTC (OTCPK:BIIO), announces the cancellation and return to treasury of 13,820,000 common shares of the companys stock. The stock transactions will soon be represented in reports filed with the United States Securities and Exchange Commission (SEC). GlobeNewswire Inc

Dec 3, 2020

09:15AM EST Bionovate Technologies Corp., traded on the Nasdaq OTC (OTCPK:BIIO), plans to strategically invest in startups in Europe in the health and life care sector and focus its investments strategy towards on-demand healthcare services. The company is in the process of building a shortlist of startups which have the potential of disrupting their respective industry. GlobeNewswire Inc

Nov 27, 2020

09:45AM EST The medical device company Bionovate Technologies Corp adopts a strategic reorientation under new management. Aleksandar Vucak will realign the company as CEO after taking over the majority of the shares of the company, traded on the Nasdaq OTC (OTCPK:BIIO). GlobeNewswire Inc

Oct 17, 2020

10:35AM EDT The Berlin public relations agency wins the business with international PR and strategic corporate communications of the medical device company Bionovate Technologies Corp. The shares of the company are traded on the Nasdaq OTC (OTCPK:BIIO). GlobeNewswire Inc

Share